01:30pm Chair Introduction

Yossi Schwartz, Professor, Ichan School of Medicine at Mount Sinai

01:35pm Presentation: Managing Patient Material – An Industry Perspective

• Patient material, a supply chain within a supply chain
• Transporting cells in a post COVID environment
• Availing CAR-T treatment globally and building an inclusive supply chain

Jean Stanton, Director, Commercial Apheresis Operations, Janssen

01:50pm Presentation: Using Data to Optimize Cell Collections

How one manufacturer uses data to maximize CD34 yield by investigating the mobilization impact on apheresis.

• During this 15-minute panel presentation by Vertex Pharmaceuticals you will see how their cell collections started, how it’s going, and where it’s going next for optimizing their cell and gene therapy process.

Jennifer Collins, Principal, Apheresis and Infusion Specialist, Vertex Pharmaceuticals

02:05pm Presentation: Collections by Apheresis – the Academic Medical Center Perspective

• Describe the process of implementing cellular therapy collections at an academic medical center
•  Detail the challenges faced by apheresis collection centers when collecting cellular therapy products

Yara Park, Professor and Director, University of North Carolina

02:20pm Presentation: Operational Complexities Related to the Leukapheresis Supply Chain

• Optimizing leukapheresis supply chains by standardizing collection, processing and distribution
• Integrating supply chain activities to support unified data streams and integration of physical material management
• Increasing patient and donor access by leveraging community collection

Mark Sawicki, President & Chief Executive Officer, CryoPort

02:35pm Closing Panel with Q&A

With all session participants, joined by: 

William Shingler, Head of Patient and Cell Management, Autolus